Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 737340

Pharmacoeconomic Modelling of Alzheimer`s Disease – Assessment of Memantine in Treating Moderate to Severe Alzheimer Patients


Benković, Vanesa; Mimica, Ninoslav; Stevanović, Ranko
Pharmacoeconomic Modelling of Alzheimer`s Disease – Assessment of Memantine in Treating Moderate to Severe Alzheimer Patients // Acta clinica Croatica
Pula, Hrvatska, 2011. str. 104-104 (predavanje, međunarodna recenzija, sažetak, ostalo)


CROSBI ID: 737340 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Pharmacoeconomic Modelling of Alzheimer`s Disease – Assessment of Memantine in Treating Moderate to Severe Alzheimer Patients

Autori
Benković, Vanesa ; Mimica, Ninoslav ; Stevanović, Ranko

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo

Izvornik
Acta clinica Croatica / - , 2011, 104-104

Skup
51 st International Neuropsychiatric Pula Congress

Mjesto i datum
Pula, Hrvatska, 15.06.2011. - 18.06.2011

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Pharmacoeconomic Modelling; Alzheimer`s Disease; Memantine; Moderate; Severe
(Pharmacoeconomic Modelling; Alzheimer`s Disease; memantine; moderate; severe)

Sažetak
In treating of moderate to severe Alzheimer patients, N-methyl D-aspartat antagonist memantine has demonstarated better results and correlations with decreased hospitalization rate, thus decreasing total health costs. Most of pharmacoeconomic studies for this disease consider societal perspective using cost effectiveness principle and QUALY parameters. This paper considers payer perspective (Croatian Department for Health Insurance) and takes into account direct cost of the disease as requested in Croatian guidelines for drugs reimbursement. Due to lack of (inaccurate) epidemiological data, authors have undertaken further data search : the paper demonstrates cost variables taken from Croatian real life environment of treating Alzheimer patients. The aim of the paper was to assess direct cost of illness with and without treatment with memantine, through three year perspective. Markov model method was created for Croatian case to assess effect of the drug on hospitalization frequency and other direct treatment costs. Model stability was tested with Monte Carlo simulations. Results demonstrate memantine domination in terms of efficiency and cost reduction, bringing cost saving not only to health budget of the payer, but also to other hospital related costs.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Zagreb,
Klinika za psihijatriju Vrapče

Profili:

Avatar Url Vanesa Benković (autor)

Avatar Url Ranko Stevanović (autor)

Avatar Url Ninoslav Mimica (autor)


Citiraj ovu publikaciju:

Benković, Vanesa; Mimica, Ninoslav; Stevanović, Ranko
Pharmacoeconomic Modelling of Alzheimer`s Disease – Assessment of Memantine in Treating Moderate to Severe Alzheimer Patients // Acta clinica Croatica
Pula, Hrvatska, 2011. str. 104-104 (predavanje, međunarodna recenzija, sažetak, ostalo)
Benković, V., Mimica, N. & Stevanović, R. (2011) Pharmacoeconomic Modelling of Alzheimer`s Disease – Assessment of Memantine in Treating Moderate to Severe Alzheimer Patients. U: Acta clinica Croatica.
@article{article, author = {Benkovi\'{c}, Vanesa and Mimica, Ninoslav and Stevanovi\'{c}, Ranko}, year = {2011}, pages = {104-104}, keywords = {Pharmacoeconomic Modelling, Alzheimer`s Disease, Memantine, Moderate, Severe}, title = {Pharmacoeconomic Modelling of Alzheimer`s Disease – Assessment of Memantine in Treating Moderate to Severe Alzheimer Patients}, keyword = {Pharmacoeconomic Modelling, Alzheimer`s Disease, Memantine, Moderate, Severe}, publisherplace = {Pula, Hrvatska} }
@article{article, author = {Benkovi\'{c}, Vanesa and Mimica, Ninoslav and Stevanovi\'{c}, Ranko}, year = {2011}, pages = {104-104}, keywords = {Pharmacoeconomic Modelling, Alzheimer`s Disease, memantine, moderate, severe}, title = {Pharmacoeconomic Modelling of Alzheimer`s Disease – Assessment of Memantine in Treating Moderate to Severe Alzheimer Patients}, keyword = {Pharmacoeconomic Modelling, Alzheimer`s Disease, memantine, moderate, severe}, publisherplace = {Pula, Hrvatska} }




Contrast
Increase Font
Decrease Font
Dyslexic Font